Interestingly, a recent report including Dutch patients with undifferentiated arthritis and comparing anti-CCP2, anti-CCP3, anti-citrullinated vimentin, and RF showed that anti-CCP2 tended to achieve the highest PPV for RA development [19]. This evidence concerns the gene VIM and rheumatoid arthritis.